C Wiesner
Overview
Explore the profile of C Wiesner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
127
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Corredor C, Pineros M, Wiesner C, de Vries E
BMC Cancer
. 2024 Feb;
24(1):232.
PMID: 38373947
No abstract available.
2.
Wenk A, Becker U, Klawitter S, Wiesner C, Bernhardt A
Value Health
. 2016 May;
17(7):A522.
PMID: 27201638
No abstract available.
3.
Meusel O, Droba M, Noll D, Schulte K, Schneider P, Wiesner C
Rev Sci Instrum
. 2016 Mar;
87(2):02B937.
PMID: 26932109
The transport of intense ion beams is affected by the collective behavior of this kind of multi-particle and multi-species system. The space charge expressed by the generalized perveance dominates the...
4.
Walzer S, Nuijten M, Wiesner C, Kaier K, Johansson P, Oertel S
Front Pharmacol
. 2013 Feb;
4:17.
PMID: 23423475
Introduction: In economic theory economic surplus refers to two related quantities: Consumer and producer surplus. Applying this theory to health care "convenience" could be one way how consumer benefits might...
5.
Rabitsch W, Milasowszky N, Nehring S, Wiesner C, Wolter C, Essl F
J Fish Biol
. 2013 Jan;
82(1):17-33.
PMID: 23331135
This study examines the invasion history of alien fish species based on exhaustive national data sets on fish invasions of two contiguous central European countries (Germany and Austria). Fifteen alien...
6.
Tsaur I, Makarevic J, Juengel E, Gasser M, Waaga-Gasser A, Kurosch M, et al.
Br J Cancer
. 2012 Jul;
107(5):847-55.
PMID: 22782340
Background: Inhibitors of the mammalian target of rapamycin (mTOR) might become a novel tool to treat advanced prostate cancer. However, chronic drug exposure may trigger resistance, limiting the utility of...
7.
Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro
Mani J, Vallo S, Barth K, Makarevic J, Juengel E, Bartsch G, et al.
Prostate Cancer Prostatic Dis
. 2012 Mar;
15(3):250-5.
PMID: 22450844
Background: The influence of the bisphosphonate zoledronic acid (ZA) on prostate cancer (PC) growth, adhesion and invasive behavior was investigated. Methods: PC-3, DU-145 and LNCaP cells were treated with ZA,...
8.
Huang W, Fridman Y, Bonfil R, Ustach C, Conley-LaComb M, Wiesner C, et al.
Oncogene
. 2011 Dec;
31(42):4527-35.
PMID: 22158043
Although increasing evidence suggests a critical role for platelet-derived growth factor (PDGF) receptor β (β-PDGFR) signaling in prostate cancer (PCa) progression, the precise roles of β-PDGFR and PDGF isoform-specific cell...
9.
Wiesner C, Haferkamp A
Urologe A
. 2011 Jun;
50(7):853-60.
PMID: 21678107
Metastatic renal cell carcinoma has a poor prognosis with a median overall survival rate of approximately 2 years. The current standard medicinal therapy includes the use of tyrosine kinase inhibitors...
10.
Amatschek S, Lucas R, Eger A, Pflueger M, Hundsberger H, Knoll C, et al.
Br J Cancer
. 2010 Dec;
104(3):469-79.
PMID: 21179030
Background: Metastasis is associated with poor prognosis for melanoma. The formation of metastases is a multi-step process, in which cancer cells can subsequently acquire the potential to intravasate into the...